Showing 441 - 460 results of 1,793 for search '"HIV"', query time: 0.06s Refine Results
  1. 441

    Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature by Clara Bertuzzi, Elena Sabattini, Francesco Bacci, Claudio Agostinelli, Gian Gaetano Ferri

    Published 2019-01-01
    “…Human immune deficiency virus- (HIV-) infected individuals present a higher risk of developing malignancies. …”
    Get full text
    Article
  2. 442

    Empedobacter brevis Bacteremia in a Patient Infected with HIV: Case Report and Review of Literature by Syed Bokhari, Naeem Abbas, Manisha Singh, Richard B. Cindrich, Cosmina Zeana

    Published 2015-01-01
    “…We report the first case of E. brevis bacteremia in a patient with HIV and review the current literature. A 69-year-old man with human immunodeficiency virus (HIV) and CD4 count of 319 presented with chief complaints of black tarry stools, nausea and vomiting for 2 days. …”
    Get full text
    Article
  3. 443

    Evaluation of Provider Screening Practices for Fracture Risk Assessment among Patients with HIV Disease by Faryal Mirza, Sabina Zawadzka, Anne Abbate, Michael Thompson, Dorothy Wakefield, Lisa M. Chirch

    Published 2021-01-01
    “…People living with HIV are known to have greater risk of low bone mineral density than HIV-negative peers. …”
    Get full text
    Article
  4. 444
  5. 445

    The Changing Demographics of Women Living with HIV/AIDS in Southern Alberta from 1982 to 2006 by Liana Hwang, Jesse Raffa, Michael John Gill

    Published 2012-01-01
    “…INTRODUCTION: Women account for a growing proportion of HIV infections in Canada. This has implications with respect to prevention, diagnosis and treatment.…”
    Get full text
    Article
  6. 446
  7. 447
  8. 448

    Non-pharmaceutical interventions for people living with HIV with cognitive impairment: A scoping review. by Lucinda Stuart, Kate Alford, Jamie H Vera

    Published 2024-01-01
    “…<h4>Background</h4>Cognitive impairment (CI) in HIV is often of multifactorial causation, and remains a prominent issue in the age of effective combination antiretroviral therapy (cART), affecting approximately 14% of people living with HIV. …”
    Get full text
    Article
  9. 449

    Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia by Olivier Segeral, Yoann Madec, Boroath Ban, Vara Ouk, Chan Roeurn Hak, Clotilde Le Tiec, Eric Nerrienet, Cécile Goujard, Anne Marie Taburet, Jean Francois Delfraissy, Arnaud Fontanet

    Published 2010-01-01
    “…Adherence to antiviral therapy is important for HIV-infected people living in low- and middle-income countries, because of poor access to alternative regimens. …”
    Get full text
    Article
  10. 450

    Psychological Impacts among Older and Younger People Living with HIV/AIDS in Nanning, China by Hongjie Liu, Xin He, Judith A. Levy, Yongfang Xu, Chunpeng Zang, Xinqin Lin

    Published 2014-01-01
    “…Objectives. The HIV epidemic has drastically increased among older adults in China, yet little research has examined the psychological impacts among older and younger people living with HIV/AIDS (PLWHAs). …”
    Get full text
    Article
  11. 451

    Impact of Novel Resistance Profiles in HIV-1 Reverse Transcriptase on Phenotypic Resistance to NVP by Liyan Jiao, Hanping Li, Lin Li, Daomin Zhuang, Yongjian Liu, Zuoyi Bao, Siyang Liu, Jingyun Li

    Published 2012-01-01
    “…To clarify the impact of H221Y mutation on drug resistance to NVP. Methods. 646 bp HIV-1 pol gene fragments (from 592 to 1237 nucleotide) with different NNRTIs mutation profiles from AIDS patients receiving antiretroviral therapy containing NVP regimens were introduced into pNL4-3 backbone plasmid. …”
    Get full text
    Article
  12. 452

    Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients by Stefanie Kuerten, Tobias R. Schlingmann, Tarvo Rajasalu, Doychin N. Angelov, Paul V. Lehmann, Magdalena Tary-Lehmann

    Published 2008-01-01
    “…Therefore, in the present study we tested the effects of IL-7/IL-15, IFN-α, anti-ICOS, and anti-CD28 on antigen-specific T cell responses in patients infected with HCV or HIV versus healthy individuals. Our data show that none of the aforementioned molecules could significantly increase ELISPOT sensitivity, neither in HCV nor in HIV. …”
    Get full text
    Article
  13. 453
  14. 454
  15. 455

    The Development of Criteria for the Selection of Chinese Peer Educators in HIV Management: A Delphi Study by Yan Qiu, Jiayin Shen, Hongzhou Lu

    Published 2016-01-01
    “…To develop an expert consensus opinion of the criteria for selection of peer educator for HIV/AIDS care program, twenty experts were invited to complete a two-round Delphi consultation. …”
    Get full text
    Article
  16. 456

    CoMFA and CoMSIA Studies on Inhibitors of HIV-1 Integrase - Bicyclic Pyrimidinones by V. Radhika, S. Sree Kanth, M. Vijjulatha

    Published 2010-01-01
    “…To understand the structural requirements of HIV-1 integrase inhibitors and to design new ligands against human HIV-1 integrase with enhanced inhibitory potency, a 3D QSAR (quantitative structure-activity relationship) study with comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) for a dataset of 35 bicyclic pyrimidinones which are inhibitors of human HIV-1 integrase was performed. …”
    Get full text
    Article
  17. 457

    The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers by Terkimbi Dominic Swase, Ilemobayo Victor Fasogbon, Ifie Josiah Eseoghene, Ekom Monday Etukudo, Solomon Adomi Mbina, Chebet Joan, Reuben Samson Dangana, Chinyere Anyanwu, Comfort Danchal Vandu, A. B Agbaje, Tijjani Salihu Shinkafi, Ibrahim Babangida Abubarkar, Patrick Maduabuchi Aja

    Published 2025-02-01
    “…Abstract Background Human papillomavirus (HPV) and human immunodeficiency virus (HIV) co-infection present a significant impact on women's health globally, especially in immunocompromised individuals. …”
    Get full text
    Article
  18. 458
  19. 459
  20. 460